Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03641924 · ClinicalTrials.gov registry record
Cognition and Psychotherapy in PTSD
A clinical trial, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- 110
- Enrollment target
NCT03641924: Completed study, sponsored by VA Office of Research and Development.
NCT03641924 is a clinical trial that has completed, run by VA Office of Research and Development. The registered enrollment target is 110 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03641924 has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- 110 participants
- Enrollment target
Study Summary
Posttraumatic stress disorder (PTSD) is prevalent among combat Veterans and is a substantial public health burden. Several psychotherapies, including cognitive processing therapy (CPT) and prolonged exposure therapy, have been recommended as efficacious for the treatment of PTSD and are being disseminated nationally in the VA Healthcare System. Yet many individuals show limited benefit from such treatments. Accumulating evidence indicates that episodic memory deficits may be one factor limiting psychotherapy treatment efficacy in PTSD. The proposed study will determine whether verbal memory is a specific predictor of CPT outcomes in PTSD, including both symptom reductions and functional outcomes. The study will also determine the pathways by which memory functioning affects treatment outcomes by examining relationships between memory functioning, treatment engagement, recall of treatment content, and illness course. More specifically, analyses will examine whether memory for treatment content affects the relationship between memory functioning and treatment outcomes.
Primary Outcome
PTSD Symptoms. The range of the scale is from 0 (no symptoms) to 80 (maximal symptoms). Higher scores corresponds to more symptoms.
Interventions
- BEHAVIORAL Cognitive Processing Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2019-05-20 |
| Est. Completion | 2023-09-29 |
What the finished NCT03641924 record still lists
NCT03641924 is an observational study that tracks outcomes without assigning an intervention. The registered 110 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Cognitive Processing Therapy is the first listed.
NCT03641924 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03641924 about?
NCT03641924 is a clinical study titled "Cognition and Psychotherapy in PTSD". Posttraumatic stress disorder (PTSD) is prevalent among combat Veterans and is a substantial public health burden. Several psychotherapies, including cognitive processing therapy (CPT) and prolonged exposure therapy, have been recommended as efficacious for the treatment of PTSD and are being dissem...
What is the current status of trial NCT03641924?
This trial is currently completed. The enrollment target is 110 participants. The study started on 2019-05-20. Estimated completion is 2023-09-29.
What interventions are being tested in trial NCT03641924?
The interventions under investigation include: Cognitive Processing Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT03641924?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01530373 · 110 participants · Phase 2
Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients
- NCT02379377 · 110 participants · Phase 1
18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant
- NCT02411773 · 110 participants · Phase 1
Sympatholysis in Chronic Kidney Disease
- NCT03190941 · 110 participants · Phase 1
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI